We are live on ! Find out more
SURF

Surface Oncology, Inc. Common Stock

Delisted

SURF was delisted on the 7th of September, 2023.

47 hedge funds and large institutions have $44.4M invested in Surface Oncology, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 20 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

13% less funds holding

Funds holding: 5447 (-7)

40% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 20

43% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 14

43% less capital invested

Capital invested by funds: $78.4M → $44.4M (-$34M)

Holders
47
Holders Change
-7
Holders Change %
-12.96%
% of All Funds
1.02%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
12
Reduced
20
Closed
14
Calls
Puts
Net Calls
Net Calls Change

SURF Hedge Fund Activity: Q2 2019 in Review

47 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Surface Oncology, Inc. Common Stock (SURF) for Q2 2019, worth a combined $44.4M — down 43% from $78.4M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of SURF and 8 opened new positions — a net loss of 6 holders — while 20 trimmed existing stakes and 12 added.

The largest buyer was BVF Inc, adding an estimated $2.27M. The largest seller was BlackRock, cutting an estimated $1.96M.

  • 47 institutional investors held Surface Oncology, Inc. Common Stock (SURF) as of Q2 2019, down from 54 in Q1 2019.
  • Funds reported $44.4M of Surface Oncology, Inc. Common Stock stock for Q2 2019, down 43% quarter-over-quarter.
  • 8 funds opened new Surface Oncology, Inc. Common Stock positions in Q2 2019 and 14 closed out, a net change of -6 holders.
  • The largest Surface Oncology, Inc. Common Stock buyer in Q2 2019 was BVF Inc, an estimated $2.27M added.
  • The largest Surface Oncology, Inc. Common Stock seller in Q2 2019 was BlackRock, an estimated $1.96M sold.

Based on aggregated 13F filings for Q2 2019.